Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rule 38.5 - Pfizer INC

19th Nov 2015 10:49

RNS Number : 2903G
Morgan Stanley & Co. Int'l plc
19 November 2015
 



 

 FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

 

1. KEY INFORMATION

 Name of exempt market-maker

Morgan Stanley & Co. International plc

 Company dealt in

PFIZER INC

 Class of relevant security to which the dealings being disclosed relate (Note 1)

US$0.05 COMMON STOCK

 Date of dealing

18 NOVEMBER 2015

 

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  2,312

 31.2750 EUR

 30.9350 EUR

  8,096

 33.3100 USD

 33.0278 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  2,344

 31.2750 EUR

 30.9793 EUR

  8,096

 33.3100 USD

 33.0278 USD

 

 

(b) Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

(Note 4)

 Number of relevant securities

(Note 5)

 Price per unit

 CFD

 LONG

 130

 31.0230 EUR

 CFD

 SHORT

 98

 30.9660 EUR

 CFD

 LONG

 4,052

 33.0300 USD

 CFD

 LONG

 765

 33.0300 USD

 CFD

 LONG

 1,186

 33.0300 USD

 CFD

 LONG

 869

 33.2245 USD

 CFD

 LONG

 398

 33.2600 USD

 CFD

 LONG

 50,833

 33.2845 USD

 CFD

 LONG

 809

 33.3100 USD

 CFD

 SHORT

 5,170

 33.2256 USD

 CFD

 SHORT

 1,814

 33.2281 USD

 CFD

 SHORT

 65

 33.2400 USD

 CFD

 SHORT

 10,225

 33.3115 USD

 

 

(c) Options transactions in respect of existing relevant securities

 

i) Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 19 NOVEMBER 2015

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ALLERGAN PLC

Nature of connection (Note 6)

Advisory

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEPKCDQKBDDODD

Related Shares:

PFZ.L
FTSE 100 Latest
Value8,680.29
Change47.96